Trial Profile
REGEN Phase I Dose Escalation Study for MyoCell SDF-1
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 17 Jan 2011
Price :
$35
*
At a glance
- Drugs Muscle-derived autologous stem cell therapy Bioheart (Primary)
- Indications Heart failure
- Focus Adverse reactions; Pharmacodynamics
- Acronyms REGEN